-transparent.png){kind=logo}
1,4-Oxazinone derivatives of the phenoxazinone chromophore in actinomycin D (AMD) have been synthesized by condensation of AMD with alpha-keto acids. By varying the starting alpha-keto acid, the substitutions on the oxazinone ring and, consequently, the lipophilicity of the molecule could be altered. These oxazinone derivatives revert to AMD in physiological media and it appears that these oxazinones are "depot" forms of AMD and possess physicochemical and DNA-binding properties which are significantly different from those of AMD. The oxazinones, which have bulky and lipophilic substituents at position 3, demonstrate more pronounced antitumor activity against P388 mouse leukemia and are less toxic than AMD.
S K Sengupta, and
D H Trites, and
M S Madhavarao, and
W R Beltz
October 1982,
Journal of medicinal chemistry,
S K Sengupta, and
D H Trites, and
M S Madhavarao, and
W R Beltz
August 1988,
Journal of medicinal chemistry,
S K Sengupta, and
D H Trites, and
M S Madhavarao, and
W R Beltz
January 1974,
Cancer chemotherapy reports,
S K Sengupta, and
D H Trites, and
M S Madhavarao, and
W R Beltz
January 1956,
Giornale italiano di chemioterapia,
S K Sengupta, and
D H Trites, and
M S Madhavarao, and
W R Beltz
January 1979,
Farmakologiia i toksikologiia,
S K Sengupta, and
D H Trites, and
M S Madhavarao, and
W R Beltz
January 2023,
PeerJ,
S K Sengupta, and
D H Trites, and
M S Madhavarao, and
W R Beltz
July 1964,
The Medical journal of Australia,
S K Sengupta, and
D H Trites, and
M S Madhavarao, and
W R Beltz
September 1964,
The Medical journal of Australia,
S K Sengupta, and
D H Trites, and
M S Madhavarao, and
W R Beltz
September 2008,
Cancer letters,
S K Sengupta, and
D H Trites, and
M S Madhavarao, and
W R Beltz
February 1976,
Cancer research,
